• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种药物可抑制磷脂酶A2诱导的内皮细胞单层高通透性。

Three drugs inhibit phospholipase A2-induced high permeability of endothelial monolayers.

作者信息

Chen S F, Li S H, Ding F Y

机构信息

Department of Pathophysiology, Second Military Medical University, Shanghai, China.

出版信息

Zhongguo Yao Li Xue Bao. 1994 Jul;15(4):299-302.

PMID:7801767
Abstract

The permeability of aortic endothelial monolayers to fluid and albumin increased 13.5 and 16.1 times respectively after pretreatment with phospholipase A2 (PLA2, 100 U.ml-1) for 30 min. 1-(p-Chlorobenzoyl)-5-methylindole-3-acetic acid (1.16 mmol.L-1), SRI 63-441 (30 nmol.L-1), and 1,25-dihydroxycholecalciferol (0.1 mumol.L-1) decreased PLA2-induced high permeability. PLA2 did not damage the endothelial cells significantly. Our results indicate that the action of PLA2 to increase the permeability of endothelial monolayers is mainly due to PLA2-induced lipid mediators released from endothelial cells.

摘要

用磷脂酶A2(PLA2,100 U.ml-1)预处理30分钟后,主动脉内皮单层对液体和白蛋白的通透性分别增加了13.5倍和16.1倍。1-(对氯苯甲酰基)-5-甲基吲哚-3-乙酸(1.16 mmol.L-1)、SRI 63-441(30 nmol.L-1)和1,25-二羟基胆钙化醇(0.1 mumol.L-1)可降低PLA2诱导的高通透性。PLA2对内皮细胞没有明显损伤。我们的结果表明,PLA2增加内皮单层通透性的作用主要是由于PLA2诱导内皮细胞释放脂质介质。

相似文献

1
Three drugs inhibit phospholipase A2-induced high permeability of endothelial monolayers.三种药物可抑制磷脂酶A2诱导的内皮细胞单层高通透性。
Zhongguo Yao Li Xue Bao. 1994 Jul;15(4):299-302.
2
Phospholipase A2-induced lung edema and its mechanism in isolated perfused guinea pig lung.磷脂酶A2诱导的离体灌注豚鼠肺肺水肿及其机制
Inflammation. 1990 Jun;14(3):267-73. doi: 10.1007/BF00915811.
3
Phospholipase A2-induced pulmonary and hemodynamic responses in the guinea pig. Effects of enzyme inhibitors and mediators antagonists.磷脂酶A2诱导的豚鼠肺部和血流动力学反应。酶抑制剂和介质拮抗剂的作用。
Am Rev Respir Dis. 1990 Nov;142(5):1193-9. doi: 10.1164/ajrccm/142.5.1193.
4
Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist.血小板活化因子拮抗剂对眼血管通透性的非前列腺素依赖性抑制作用。
Arch Ophthalmol. 1988 Aug;106(8):1116-20. doi: 10.1001/archopht.1988.01060140272040.
5
The effects of neutrophils and phospholipase A2 on transvascular albumin flux in isolated rabbit lungs.中性粒细胞和磷脂酶A2对离体兔肺血管白蛋白通量的影响。
Prostaglandins Leukot Essent Fatty Acids. 1990 Mar;39(3):167-75. doi: 10.1016/0952-3278(90)90068-v.
6
Stimulation of luteinizing hormone-releasing hormone release from perifused hypothalamic fragments by phospholipase A2.
Endocrinology. 1987 Oct;121(4):1483-6. doi: 10.1210/endo-121-4-1483.
7
Inhibitory effects of isoproterenol on PAF-induced endothelial cell permeability and morphological changes.异丙肾上腺素对血小板活化因子诱导的内皮细胞通透性及形态变化的抑制作用。
Sci China C Life Sci. 1996 Feb;39(1):80-6.
8
Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.肿瘤与药物对体外血脑屏障通透性的影响
J Neurosurg. 1995 Jun;82(6):1053-8. doi: 10.3171/jns.1995.82.6.1053.
9
Gene expression of pancreatic-type phospholipase-A2 in rat ovaries: stimulatory action on progesterone release.大鼠卵巢中胰腺型磷脂酶A2的基因表达:对孕酮释放的刺激作用。
Endocrinology. 1994 Aug;135(2):603-9. doi: 10.1210/endo.135.2.8033809.
10
Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor.肿瘤坏死因子和内毒素协同激活小鼠肠道磷脂酶A2。内源性血小板活化因子的作用及外源性血小板活化因子的影响。
Gut. 1994 Feb;35(2):215-9. doi: 10.1136/gut.35.2.215.

引用本文的文献

1
Overexpression of steroidogenic acute regulatory protein in rat aortic endothelial cells attenuates palmitic acid-induced inflammation and reduction in nitric oxide bioavailability.固醇生成急性调节蛋白在大鼠主动脉内皮细胞中的过表达可减轻软脂酸诱导的炎症和一氧化氮生物利用度降低。
Cardiovasc Diabetol. 2012 Nov 21;11:144. doi: 10.1186/1475-2840-11-144.